Zimmer Biomet just announced it’s reorganizing its entire 2,500-person U.S. salesforce — moving from independent contractors to a fully dedicated, specialized sales organization. CEO Ivan Tornos told investors the change follows a straightforward comparison: competitors with dedicated, specialized reps are more productive. About a third of the transition is done. The rest wraps by end of 2027.
If you’re Zimmer, this makes perfect sense. The U.S. is 60%+ of their revenue. They’re pushing into sports medicine, extremities, trauma, CMF, thoracic, robotics, and the ASC channel — where Tornos estimates 20–22% of hip and knee procedures already happen. A dedicated salesforce aligned to these growth segments is the obvious move.
If you’re not Zimmer — if you’re an independent manufacturer competing for the same surgeons through the same distributors — this should change how you think about the next two years.
Three Problems You Didn’t Have Yesterday
A more aligned competitor. Zimmer’s current model includes reps who aren’t fully dedicated — they carry other lines, split attention, prioritize whoever pays best that quarter. That’s about to end. A fully dedicated Zimmer rep wakes up thinking about Zimmer. They know the portfolio, they know the pricing, they know the ROSA robotics platform backward and forward. That’s a different animal than an independent rep juggling five manufacturers.
For a smaller manufacturer relying on independent distributors, this creates an alignment gap. Your distributor’s rep covers your product, plus four others, plus whatever Zimmer’s dedicated rep is actively pulling volume from. The playing field just tilted.
A leaner operations machine. This isn’t just a sales move — it’s an operations play. When you control your own salesforce, you control the data. You know what’s in the field, what’s being used, what’s sitting idle. You can centralize order processing, standardize billing, and drive down SG&A. Zimmer is willing to take a short-term hit on guidance — 2.5% to 4.5% growth in 2026, down from what analysts expected — because the margin improvement on the other side is worth it.
Meanwhile, most independent manufacturers are still running commercial operations through email chains, spreadsheets, and a customer service team that spends half their day re-keying data from charge sheets. Zimmer is about to run tighter operations at scale. If your operations are still manual, that gap compounds every quarter.
A whole-portfolio approach. Zimmer can walk into an ASC and offer hips, knees, sports medicine, trauma, robotics — a complete orthopedic solution. If you’re a niche category player with two product lines, you can’t match that breadth. And when the ASC’s materials manager wants to consolidate vendors (which they do, because reimbursement pressure is forcing it), the whole-portfolio player wins by default.
The Wrong Response
Here’s what I’ve watched small manufacturers do wrong for a decade: hire an ex-Big-4 VP of Sales and let them run the big-company playbook. Build a direct salesforce. Expand territories. Add headcount. Increase SG&A to 45% of revenue and hope volume catches up.
It never catches up. You can’t out-Zimmer Zimmer. You don’t have the portfolio, the install base, the robotics platform, or the balance sheet. Running their playbook with a fraction of their resources is how you burn through your runway and end up as an acquisition target at a discount.
The Right Response: Create Asymmetries
Winners in the independent manufacturer space aren’t going to win by competing head-to-head with juggernauts using the same strategies. You win by creating advantages that only work at your scale — things the big companies can’t or won’t do because of their own structural constraints.
Pay your distributors faster. Zimmer’s dedicated reps don’t need to choose whose product to push — they only carry Zimmer. Your distributors’ reps carry five to ten lines and make choices every day about which product gets their attention. The single most effective way to get to the top of their bag: pay them faster. Your distributors don’t want to wait 60–90 days to get paid on a case. Compress your case-to-payment cycle to days instead of weeks. When a rep knows your commission hits their account the fastest, your product gets mentioned first. This isn’t theory — having helped 100+ medical device companies build commercial strategies, I’ve seen this work consistently. The companies that pay fast get disproportionate rep mindshare.
Automate your operations to be the easiest manufacturer to work with. You can’t centralize operations like Zimmer because you don’t own the salesforce. But you can make your distributors’ lives dramatically easier. Your distributors don’t want to wait a week for shipping confirmations. They don’t want to call in every day to check if cases were processed. They don’t want to chase POs or reconcile pricing discrepancies. Be proactive — automate case confirmations, push shipping notifications, process charge sheets same-day, flag issues before they become problems. When a distributor has to choose between a manufacturer that creates work and one that eliminates it, the choice is obvious.
Help your distributors build the right portfolio. You can’t match Zimmer’s breadth alone. But you can partner with adjacent manufacturers to help your distributors curate a complete product portfolio for their surgeons. If you make hip stems and another independent makes acetabular cups, your distributor should be offering both as a system. Create the partnerships, build the co-marketing, make it easy for your distributors to walk into an ASC with a competitive total solution — even if no single manufacturer owns it all. The distributed portfolio, well-coordinated, can compete with the integrated one.
The Real Competitive Advantage
The reason independent manufacturers fail isn’t their product. Most have excellent technology, strong clinical data, and differentiated designs. They fail because they apply 2005 commercial tactics to a 2026 market.
Zimmer’s reorganization is a signal — not just about Zimmer, but about where the industry is heading. The companies that survive as independents will be the ones that figured out how to punch above their weight: faster payments creating distributor loyalty, automated operations creating partner stickiness, and collaborative portfolio strategies creating breadth without the overhead.
The playbook for independents has never been to match the big companies move for move. It’s to make your distributors so successful, so efficiently, that switching to a dedicated Zimmer rep means giving up something they don’t want to lose.